Gene and cell treatment firm Oxford Biomedica plc said on Monday it had named French pharmaceutical industry veteran Roch Doliveux as its non-official administrator, as it eyes a possibly significant job in delivering coronavirus antibody.

Doliveux, who right now fills in as a non-official chief at Stryker Corp, will take up his job at Oxford from June 24, the organization said.

A week ago, AstraZeneca reported an association with Oxford to make its test COVID-19 immunization as the drugmaker hopes to support its assembling ability to deliver one billion dosages.